Research team

Expertise

Neuropathic pain syndromes result from damage or dysfunction of the somatosensory nervous system. They are very resistant to common pain-killers and patients often suffer from terrible discomfort. Trigeminal neuralgia (“tic douloureux”) is an extreme form of facial neuropathic pain. A rat model was developed where the Infraorbital nerve (IoN), which constitutes almost the entire maxillary branch of the trigeminal nerve, is loosely ligated. Following IoN surgery, rats display increased face grooming behavior directed to the territory of the injured IoN indicative of spontaneous pain. After an initial period of hyporesponsiveness, rats also become hyperresponsive to mechanical (von Frey hair) stimulation of the IoN territory. In addition to its role in tumourigenesis and angiogenesis, evidence is accumulating that ET-1 may be of critical importance in the occurrence of cancer pain. Recently, our lab has been focusing on the effects of application of ET-1 to the infraorbital nerve (IoN) of the rat and of prolonged exposure to ET-1. Video-ECoG, or the simultaneous recording of behaviour and electrocorticography in awake animals, has become a valuable tool in neurophysiological and neuropharmacological studies. In our lab, we have begun to implement the video-ECoG methodology in the IoN-CCI model in order to correlate behavioral (grooming) data with ECoG data in normal and IoN-CCI rats.

Evaluation of biopsychosocial markers for individual phenotyping during the transition phase from (sub)acute to chronic pain using machine learning metrics, and study of the Gut Microbiota-SCFAs-GPR41 axis in trigeminal neuralgia. 01/10/2027 - 31/12/2029

Abstract

The progression from acute to chronic disabling pain involves more than the mere passage of time. It's important to understand the underlying processes and the interaction between them to elaborate a model for this transition, and this across different pain categories. Despite growing interest in targeted early interventions, the field still lacks mechanistically informed, generalizable models that can reliably identify individuals at heightened risk for pain chronification. The purpose of this research project is to gather more insights into the predictive and protective mechanisms involved in the transition from (sub)acute to chronic pain conditions. This project aims to develop a model that can recognize the transition patterns based on these (risk/protective) components. Human genetic studies have confirmed a clear link between the gut microbiota and trigeminal neuralgia. Animal experiments have demonstrated that short-chain fatty acids (SCFAs) — metabolic byproducts of the gut microbiota — can directly suppress the excitability of nociceptive neurons. This effect is mediated by the activation of G-protein-coupled receptor 41 (GPR41). However, direct experimental evidence is still scarce regarding whether gut microbiota regulate trigeminal neuralgia through the SCFAs-GPR41 pathway. This study will examine the mechanisms by which gut microbiota in trigeminal neuralgia patients modulate pain via the SCFAs-GPR41 signaling axis. Furthermore, it will examine the intervention strategy of supplementing butyrate providing a theoretical foundation and experimental support for the development of novel microbiota-targeted pain therapies.

Researcher(s)

Research team(s)

Funding

  • PRIVE - non profit

Project type(s)

  • Research Project

Study of the pain-producing and pain-potentiating effects of prolonged exposure to Endothelin-1 (ET-1) (part 4). 01/10/2020 - 31/12/2029

Abstract

Endothelin-1 is being increasingly recognized as an important molecule in the development and progression of cancer, but also in the occurrence of cancer pain. So far, all studies have used acute administration of ET-1, bearing little resemblance with the prolonged exposure observed in clinical conditions. It is therefore proposed to investigate the effects of chronic exposure to ET-1 on signs of spontaneous and evoked pain behaviour.

Researcher(s)

Research team(s)

Funding

  • PRIVE - non profit

Project type(s)

  • Research Project

In vivo testing of tool TRPM3 inhibitor in an infraorbital nerve chronic constriction injury (IoN-CCI) mouse model. 18/11/2025 - 31/12/2025

Abstract

Trigeminal neuralgia (TG) is a chronic pain condition that affects the trigeminal nerve, which carries sensation from the face to the brain. A very recent study in rodents, indicated a role of Transient Receptor Potential Melastatin 3 (TRPM3) ion channel selectively in nociception. Recently, a novel class of highly potent, selective and orally bio-available TRPM3 antagonists have been developed by researchers at KU Leuven. In the present study, the efficacy of one of these compounds, CIM133288, will be investigated in the infraorbital nerve chronic constriction injury model.

Researcher(s)

Research team(s)

Funding

  • VL. INST.

Project type(s)

  • Research Project

Study of the pain-producing and pain-potentiating effects of prolonged exposure to Endothelin-1 (ET-1) (part 3). 01/01/2022 - 31/12/2024

Abstract

Endothelin-1 is being increasingly recognized as an important molecule in the development and progression of cancer, but also in the occurrence of cancer pain. So far, all studies have used acute administration of ET-1, bearing little resemblance with the prolonged exposure observed in clinical conditions. It is therefore proposed to investigate the effects of chronic exposure to ET-1 on signs of spontaneous and evoked pain behaviour.

Researcher(s)

Research team(s)

Funding

  • PRIVE - non profit

Project type(s)

  • Research Project

Study of the pain-producing and pain-potentiating effects of prolonged exposure to Endothelin-1 (ET-1) (part 2). 01/04/2010 - 31/12/2020

Abstract

Endothelin-1 is being increasingly recognized as an important molecule in the development and progression of cancer, but also in the occurrence of cancer pain. So far, all studies have used acute administration of ET-1, bearing little resemblance with the prolonged exposure observed in clinical conditions. It is therefore proposed to investigate the effects of chronic exposure to ET-1 on signs of spontaneous and evoked pain behaviour.

Researcher(s)

Research team(s)

Funding

  • PRIVE - non profit

Project type(s)

  • Research Project

Study of the pain-producing and pain-potentiating effects of prolonged exposure to Endothelin-1 (ET-1). 01/02/2009 - 31/12/2010

Abstract

Endothelin-1 is being increasingly recognized as an important molecule in the development and progression of cancer, but also in the occurrence of cancer pain. So far, all studies have used acute administration of ET-1, bearing little resemblance with the prolonged exposure observed in clinical conditions. It is therefore proposed to investigate the effects of chronic exposure to ET-1 on signs of spontaneous and evoked pain behaviour.

Researcher(s)

Research team(s)

Funding

  • BOF

Project type(s)

  • Research Project

Study of the pain-producing and pain-potentiating effects of prolonged exposure to Endothelin-1 (ET-1) (part 1). 01/01/2007 - 31/12/2008

Abstract

Researcher(s)

Research team(s)

Funding

  • BOF

Project type(s)

  • Research Project